Repligen Q1 2024 Adj EPS $0.28 Misses $0.30 Estimate, Sales $151.346M Beat $150.062M Estimate
Portfolio Pulse from Benzinga Newsdesk
Repligen (NASDAQ:RGEN) reported Q1 2024 earnings of $0.28 per share, missing the consensus estimate of $0.30, a 56.25% decrease from last year. Sales were $151.346M, slightly above the $150.062M estimate but 17.14% lower than the previous year.
May 01, 2024 | 11:32 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Repligen's Q1 2024 earnings per share of $0.28 missed estimates by 6.67%, and sales of $151.346M slightly beat estimates but showed a significant year-over-year decline.
The missed earnings estimate and significant year-over-year decrease in both earnings and sales are likely to negatively impact investor sentiment towards RGEN in the short term, potentially leading to a decrease in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100